Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI filing briefs · archive

8-K filings in April 2026, explained

1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

1 of 1,298 briefs matches

newest first · times in ET
ABBVAbbVie Inc. Apr 3, 4:05 PM ET

AbbVie cuts 2026 EPS guidance after $744 million first-quarter IPR&D charge

Negative guidance Written later 2.02

AbbVie said its first-quarter 2026 results will include $744 million in pre-tax acquired IPR&D and milestones expense, reducing both GAAP and adjusted diluted EPS by $0.41. Full-year 2026 adjusted EPS guidance falls to $13.96-$14.16 from the $14.37-$14.57 range given on February 4, 2026, and AbbVie says its guidance excludes any such expense incurred after the first quarter. Shareholders face a lower earnings outlook, and the quarter's results have not been finalized.

  • Q1 2026 acquired IPR&D and milestones expense of $744 million pre-tax, an unfavorable $0.41 impact on GAAP and adjusted diluted EPS
  • Full-year 2026 adjusted diluted EPS guidance now $13.96-$14.16, versus $14.37-$14.57 previously
  • Q1 2026 adjusted diluted EPS guidance now $2.56-$2.60, versus $2.97-$3.01 before the charge
  • Quarter ended March 31, 2026 results not finalized and may differ from these preliminary estimates
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.